Related Experiment Videos
Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease
1University of Oklahoma Health Sciences Center, Biomedical Research Center, Oklahoma City, OK 73104, USA. madeleine-cunningham@ouhsc.edu
Abstract:
Molecular mimicry between pathogen and host has been proposed as a mechanism for the development of autoimmune diseases. Evidence suggests that microorganisms contain proteins which are similar enough to host proteins that they can stimulate existing B and T cells to respond to self proteins. The loss of immune regulation during responses against microbial antigens may explain development of pathogenic B and T cell responses in autoimmune diseases associated with infections. The study of B and T cell responses against the group A streptococcal antigens, N-acetyl-glucosamine, M protein and the autoantigen cardiac myosin has led to a better understanding of how molecular mimicry may play a role in disease. Studies of human monoclonal antibodies, T cell responses and animal models in comparison with the immunopathology in the human disease has provided information about the steps leading to inflammatory heart disease in autoimmune post-streptococcal rheumatic carditis. The new data indicate that the steps in pathogenesis of rheumatic heart disease following group A streptococcal infection include the following events. First, the development of crossreactive autoantibodies against the group A streptococcal carbohydrate antigen N-acetyl-glucosamine and cardiac myosin. Second, these antibodies react with valvular endothelium which becomes inflamed with expression of vascular cell adhesion molecule-1 (VCAM-1). After this event, T cells, CD4+ and CD8+, infiltrate through the endothelium/endocardium into the valve which is an avascular structure. Aschoff bodies or granulomatous lesions may form containing macrophages and T cells underneath the endocardium. The T cells are responsive to streptococcal M protein antigen sequences. The valve becomes scarred with eventual neovascularization and progressive, chronic disease in the valve. In the host, the mimicking antigens cardiac myosin and laminin have been involved in the myocardium and valve, respectively. As in other autoimmune diseases, both environmental and genetic factors are involved in the development of rheumatic carditis and inflammatory heart disease, a result of mimicry between the group A streptococcus and heart.
Insights
Molecular mimicry, where pathogen proteins resemble host proteins, can trigger autoimmune diseases like rheumatic heart disease. Group A Streptococcus infection leads to cross-reactive antibodies and T cell responses targeting heart tissues, causing inflammation and scarring.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Microbiology
Background:
- Molecular mimicry is a proposed mechanism for autoimmune disease development.
- Microbial proteins can resemble host proteins, activating self-reactive B and T cells.
- Loss of immune regulation during microbial responses can lead to autoimmunity.
Purpose of the Study:
- To investigate the role of molecular mimicry in post-streptococcal rheumatic carditis.
- To elucidate the steps in the pathogenesis of rheumatic heart disease following group A Streptococcus infection.
Main Methods:
- Studied B and T cell responses to group A streptococcal antigens (N-acetyl-glucosamine, M protein) and cardiac myosin.
- Analyzed human monoclonal antibodies, T cell responses, and animal models.
- Compared findings with human immunopathology of rheumatic carditis.
Main Results:
- Group A Streptococcus infection triggers cross-reactive autoantibodies against N-acetyl-glucosamine and cardiac myosin.
- These antibodies target valvular endothelium, leading to inflammation (VCAM-1 expression).
- CD4+ and CD8+ T cells infiltrate the valve, forming granulomatous lesions (Aschoff bodies) and causing scarring.
Conclusions:
- Molecular mimicry between group A Streptococcus and host proteins (cardiac myosin, laminin) drives rheumatic heart disease.
- Environmental and genetic factors contribute to the development of this autoimmune condition.
- The process involves autoantibody formation, T cell infiltration, and chronic valvular inflammation and scarring.